NEOG 17.24 (+2.19%)
US6404911066Medical Diagnostics & ResearchDiagnostics & Research

Neogen (NEOG) Competitor Comparison

We are evaluating the key criteria listed to compare Neogen (NEOG) against its competitors in the Diagnostics & Research industry.

Linearity 10 years - NEOG ranking 1 / 58

These are the competitors of Neogen in the industry Diagnostics & Research ranked by linearity 10 years
1. Neogen NEOG
65.87
2. Guardant Health GH
57.18
3. Ortho Clinical Diagnostics Holdings OCDX
33.4
4. Inotiv NOTV
15.88
5. Illumina ILMN
13.43
6. Olink Holding OLK
8.11
7. National Research NRC
7.14
8. Pacific Biosciences of California PACB
6.6
9. Myriad Genetics MYGN
6.48
10. Global Cord Blood CO
5.67
11. Sotera Health SHC
5.43
12. DarioHealth DRIO
4.86
13. Sera Prognostics SERA
4.08
14. Bioventus BVS
3.73
15. Syneos Health SYNH
3.71
16. Fulgent Genetics FLGT
3.54
17. Anixa Biosciences ANIX
3.47
18. Co-Diagnostics CODX
3.34
19. Psychemedics PMD
3.01
20. Enzo Biochem ENZ
2.85
21. Qiagen QGEN
2.51
22. NeoGenomics NEO
2.28
23. Aspira Womens Health AWH
2.28
24. Exagen XGN
2.26
25. Twist Bioscience TWST
2.24
26. MDxHealth MDXH
2.13
27. Meridian Bioscience VIVO
2.1
28. Biodesix BDSX
2.02
29. MaxCyte MXCT
1.93
30. Personalis PSNL
1.92
31. Prenetics Global PRE
1.82
32. bioAffinity Technologies BIAF
1.77
33. Organovo Holdings ONVO
1.66
34. Neuronetics STIM
1.62
35. Exact Sciences EXAS
1.62
36. Trinity Biotech TRIB
1.56
37. SeqLL SQL
1.47
38. Laboratory Corp of America Holdings LH
1.47
39. Charles River Laboratories CRL
1.43
40. CareDx CDNA
1.41
41. Quest Diagnostics DGX
1.4
42. Interpace Biosciences IDXG
1.24
43. PerkinElmer PKI
1.15
44. DexCom DXCM
1.13
45. Precipio PRPO
1.09
46. Waters WAT
1.03
47. Agilent Technologies A
0.87
48. IQVIA Holdings IQV
0.63
49. Mettler-Toledo MTD
0.52
50. Heska HSKA
0.52
51. RadNet RDNT
0.44
52. Natera NTRA
0.41
53. Thermo Fisher Scientific TMO
0.4
54. Lantheus Holdings LNTH
0.39
55. IDEXX Laboratories IDXX
0.36
56. Danaher DHR
0.34
57. Icon ICLR
0.34
58. Medpace Holdings MEDP
0.25

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.